Committee Biography

Dr. Maurice Dahdaleh graduated from Westminster Medical School (Imperial College), London University and did his training in Internal Medicine and Neurology in the United Kingdom. He is a Fellow of the Royal College of Physicians, London. He worked in Jordan at the Jordan University Hospital and Medical School as part-time Lecturer and Consultant Neurologist. He developed several interests in Clinical Neurology mainly Multiple Sclerosis, Cerebrovascular disease and Movement Disorders. He is member of many local, regional and international neurological societies and past Chair of Scientific Committee and President of the Jordanian Neuroscience Society. In 1994 he introduced beta-interferon 1a for the first time in Jordan on a patient named basis for the treatment of patients with multiple sclerosis. In addition he pioneered the introduction of botulinum toxin in the treatment of focal dystonia and spasticity in the early 1990 and thrombolytic therapy in the management of acute stroke in 1996. From 1998 he worked in the United Kingdom as honorary Consultant Neurologist at St. Mary’s Hospital, London. He returned to Amman Jordan in 2008 as Consultant Neurologist mainly in the Private sector with affiliation to Khalidi Hospital Medical Center and the Arab Medical Center. He is a member of many regional advisory boards on multiple sclerosis, co-authored several papers on multiple sclerosis and is a founding member of MENACTRIMS.